---
id: FC-281
type: Flashcard
created: 2025-08-08 10:01:21.193658
tags:
- Flashcard
- question
- cardiovascular
topic: cardiovascular
answer: A
related_articles:
- title: SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest,
    Even in Patients With Established Heart Disease.
  path: 2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi.md
  similarity: 0.5
  link: '[[2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi|SGLT-2
    Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest, Even in Patients
    With Established Heart Disease.]]'
- title: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular
    Disease and Cancer.
  path: 2022/2022-11-vitamin-mineral-and-multivitamin-supplementation-to-prevent.md
  similarity: 0.5
  link: '[[2022/2022-11-vitamin-mineral-and-multivitamin-supplementation-to-prevent|Vitamin,
    Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and
    Cancer.]]'
- title: PREVENT Equations for Assessing Cardiovascular Risk.
  path: 2024/2024-09-prevent-equations-for-assessing-cardiovascular-risk.md
  similarity: 0.5
  link: '[[2024/2024-09-prevent-equations-for-assessing-cardiovascular-risk|PREVENT
    Equations for Assessing Cardiovascular Risk.]]'
- title: 'Prostate Cancer Screening: Common Questions and Answers.'
  path: 2024/2024-11-prostate-cancer-screening-common-questions-and-answers.md
  similarity: 0.429
  link: '[[2024/2024-11-prostate-cancer-screening-common-questions-and-answers|Prostate
    Cancer Screening: Common Questions and Answers.]]'
- title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
    Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
  path: 2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists.md
  similarity: 0.429
  link: '[[2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists|In
    Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major Adverse
    Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.]]'
topics:
- Cardiology
- Hematology/Oncology
- Neurology
- Psychiatry
related_articles_2023_2025:
- title: editorial cardiovascular disparities south asian people
  path: 2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people.md
  similarity: 0.308
  link: '[[2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people|editorial
    cardiovascular disparities south asian people]]'
last_updated: '2025-08-10T20:25:12.546224'
---

# Flashcard FC-281

## Question

A72-year-oldmanwhoreceivedtreatmentfornon-Hodgkinlymphoma10 yearsagopresentstoyour office. Histreatmentregimenincludedanthracyclinedrugs. which one of the followingconditionsisa commonlong-termcomplicationofthistreatment? Cardiovasculardisease. Bladdercancer. Lymphedema. Peripheralneuropathy. @ Back

## Answer

**A**

## Explanation

Cardiovasculardiseaseisaleadingcauseofdeathforcancersurvivors. Cliniciansshouldcounsel patientsoncessationoftobaccoandalcoholuse,participationinrecommendedlevelsofphysical activity,andadherencetooptimalnutritionrecommendations. Somechemotherapyagentsincreasethe tiskofcardiovasculardisease,includinganthracyclinedrugs,whichareassociatedwithheartfailure. e

## References

- AAFPQuestion Bank-Pythonsimplecapture.
- whoreceivedtreatmentfornon-Hodgkinlymphoma10 yearsagopresentstoyour

